Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 982–983 | Cite as

ASO Author Reflections: PD-1 Expression in Bacillus Calmette–Guérin-Relapsing Bladder Cancer

  • Keishiro Fukumoto
  • Eiji KikuchiEmail author
ASO Author Reflections



The authors have no conflicts of interest to disclose.


  1. 1.
    Ribas A. Tumor immunotherapy directed at PD-1. N Engl J Med. 2012;366:2517–9.CrossRefGoogle Scholar
  2. 2.
    Zhang Y, Kang S, Shen J, et al. Prognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) expression in epithelial-originated cancer: a meta-analysis. Medicine. 2015;94:e515.CrossRefGoogle Scholar
  3. 3.
    Fukumoto K, Kikuchi E, Mikami S, et al. The clinical role of programmed cell death-1 expression in patients with non-muscle invasive bladder cancer recurring after initial bacillus Calmette–Guérin therapy. Ann Surg Oncol. 2018; 25:2484–91.CrossRefGoogle Scholar
  4. 4.
    Nieder AM, Brausi M, Lamm D, O’Donnell M, Tomita K, Woo H, Jewett MA. Management of stage T1 tumors of the bladder: International Consensus Panel. Urology. 2005;66:108–25.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of UrologyKeio University School of MedicineTokyoJapan

Personalised recommendations